Noticias de Eulerpool Kyowa Kirin Co

Kyowa Kirin Co Noticias de Acciones

Kyowa Kirin Co es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Kyowa Kirin Co.

• 9 de diciembre ·

  Yahoo
  Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
• 24 de noviembre ·

  SeekingAlpha
  BridgeBio: Next Chapter Begins After Attruby Approval
• 20 de noviembre ·

  Yahoo
  Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
• 31 de octubre ·

  Yahoo
  Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
• 25 de septiembre ·

  Yahoo
  Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis
• 23 de agosto ·

  Yahoo
  Kyowa Kirin to end distribution of Fareston (toremefine) in the United States
• 11 de agosto ·

  SeekingAlpha
  Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront
• 2 de agosto ·

  SeekingAlpha
  Kyowa Kirin Co., Ltd. 2024 Q2 - Results - Earnings Call Presentation
• 1 de agosto ·

  Yahoo
  Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region
• 17 de junio ·

  SeekingAlpha
  Week In Review: Osaka Enters $445 Million Deal For Two Hearing Loss Candidates From France's Cilcare